Join to access to all OVN content. Join for Free
Healthy on the Road-How to Avoid MSL Belly
MSL travel health healthy eating on the road MSL workout routines managing jet lag staying hydrated during travel meal prepping for MSLs overcoming unhealthy habits

Healthy on the Road-How to Avoid MSL Belly


Share This Article


Summary

In this episode, Tom Caravela and Alex Palumbo discuss the challenges faced by Medical Science Liaisons (MSLs) to stay healthy with a crazy travel schedule and stay free from "MSL belly." They discuss strategies for overcoming unhealthy habits and maintaining healthy eating on the road. The episode offers practical tips for meal prepping, managing cravings, and staying hydrated during travels. Alex shares workout routines and gym options for traveling MSLs, plus advice on managing sleep and jet lag. Emphasizing consistency, they highlight the importance of simple activities like walking and taking stairs to maintain an active lifestyle.

Key Points

  • Maintaining a healthy lifestyle as an MSL involves careful meal prep and planning, such as bringing protein bars and knowing healthy food options at airports.
  • Incorporating exercise into a busy travel schedule can be managed by choosing hotels with good gyms, using apps to find local gyms, and even taking stairs instead of elevators.
  • Staying hydrated and ensuring adequate sleep are critical, and being transparent about your health needs in social situations can help balance professional obligations with personal well-being.

Click for Source
MSL travel health, healthy eating on the road, MSL workout routines, managing jet lag, staying hydrated during travel, meal prepping for MSLs, overcoming unhealthy habits

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
OVN Avatar S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny

Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale

Article
Sponsorship of oncology clinical trials in the United States according to age of eligibility
OVN Avatar Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois

Sponsorship of oncology clinical trials in the United States according to age of eligibility

Article
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
OVN Avatar Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li

Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?

Article
Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?
OVN Avatar Karen Geary

Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?

Article
Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
OVN Avatar J. Remon, R. García-Campelo, E. de Álava, R. Vera, J. L. Rodríguez-Peralto, Á. Rodríguez-Lescure, B. Bellosillo, P. Garrido, F. Rojo & R. Álvarez-Alegret

Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

Article
Past, Current, and Future Cancer Clinical Research Collaborations: The Case of the European Organisation for Research and Treatment of Cancer
OVN Avatar Stefanie Broes, Robbe Saesen, Denis Lacombe, Isabelle Huys

Past, Current, and Future Cancer Clinical Research Collaborations: The Case of the European Organisation for Research and Treatment of Cancer

Explore OVN